258 related articles for article (PubMed ID: 22801822)
1. Risky recreation: synthetic cannabinoids have dangerous effects.
McGuinness TM; Newell D
J Psychosoc Nurs Ment Health Serv; 2012 Aug; 50(8):16-8. PubMed ID: 22801822
[TBL] [Abstract][Full Text] [Related]
2. [Cannabis use: promoting awareness of negative sequelae].
Besançon-Quelennec D; Pouvreau C; Scerbanenko D
Krankenpfl Soins Infirm; 2007; 100(12):22-4. PubMed ID: 18229729
[No Abstract] [Full Text] [Related]
3. Myocardial infarction associated with use of the synthetic cannabinoid K2.
Mir A; Obafemi A; Young A; Kane C
Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
5. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
[TBL] [Abstract][Full Text] [Related]
7. [Synthetic cannabinoids--the new "legal high" drugs].
Berkovitz R; Arieli M; Marom E
Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
[TBL] [Abstract][Full Text] [Related]
8. Synthetic cannabinoid and marijuana exposures reported to poison centers.
Forrester MB; Kleinschmidt K; Schwarz E; Young A
Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
[TBL] [Abstract][Full Text] [Related]
9. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
Tung CK; Chiang TP; Lam M
East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
[TBL] [Abstract][Full Text] [Related]
10. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
Seely KA; Lapoint J; Moran JH; Fattore L
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):234-43. PubMed ID: 22561602
[TBL] [Abstract][Full Text] [Related]
11. Toxicological findings of synthetic cannabinoids in recreational users.
Kronstrand R; Roman M; Andersson M; Eklund A
J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
[TBL] [Abstract][Full Text] [Related]
12. Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.
Keyes KM; Rutherford C; Hamilton A; Palamar JJ
Drug Alcohol Depend; 2016 Sep; 166():159-67. PubMed ID: 27491817
[TBL] [Abstract][Full Text] [Related]
13. Should we recriminalize cannabis use? The case against.
Hall W; Room R
Can J Psychiatry; 2008 Dec; 53(12):793-4. PubMed ID: 19087474
[No Abstract] [Full Text] [Related]
14. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
Benford DM; Caplan JP
Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
[No Abstract] [Full Text] [Related]
15. K2 and Spice use among a cohort of college students in southeast region of the USA.
Egan KL; Suerken CK; Reboussin BA; Spangler J; Wagoner KG; Sutfin EL; Debinski B; Wolfson M
Am J Drug Alcohol Abuse; 2015; 41(4):317-22. PubMed ID: 26030768
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
17. Synthetic marijuana use and development of catatonia in a 17-year-old male.
Smith DL; Roberts C
Minn Med; 2014 May; 97(5):38. PubMed ID: 24941587
[No Abstract] [Full Text] [Related]
18. Update on marijuana.
McGuinness TM
J Psychosoc Nurs Ment Health Serv; 2009 Oct; 47(10):19-22. PubMed ID: 19835316
[TBL] [Abstract][Full Text] [Related]
19. Synthetic cannabinoid use: recognition and management.
Castellanos D; Thornton G
J Psychiatr Pract; 2012 Mar; 18(2):86-93. PubMed ID: 22418399
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes.
Egan KL; Erausquin JT; Milroy JJ; Wyrick DL
J Psychoactive Drugs; 2016; 48(3):166-72. PubMed ID: 27224428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
